Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 359

    FDA OKs Merck drug that prevents infection post-stem cell transplant

    FDA OKs Merck drug that prevents infection post-stem cell transplant

    Ruby Khatun Khatun11 Nov 2017 10:01 AM IST
    Merck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
    Dynavax hepatitis B vaccine gets FDA nod on third try, shares up

    Dynavax hepatitis B vaccine gets FDA nod on third try, shares up

    Ruby Khatun Khatun11 Nov 2017 9:45 AM IST
    Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
    Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales

    Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales

    Ruby Khatun Khatun11 Nov 2017 9:30 AM IST
    Regeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
    Granules India posts Q2 net profit at Rs 40 crore

    Granules India posts Q2 net profit at Rs 40 crore

    Ruby Khatun Khatun10 Nov 2017 10:47 AM IST
    New Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current...
    Piramal group expands healthcare project ASARA

    Piramal group expands healthcare project ASARA

    Ruby Khatun Khatun10 Nov 2017 10:31 AM IST
    Vishakhapatnam: Piramal Swasthya, an initiative under the aegis of Piramal Foundation (the philanthropic arm of the Piramal Group), announced the...
    Novartis takes fight to Pfizers Ibrance with new Kisqali data

    Novartis takes fight to Pfizers Ibrance with new Kisqali data

    Ruby Khatun Khatun10 Nov 2017 10:17 AM IST
    ZURICH: New data from Novartis's breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid...
    GSK appoints scientist Barron as new Research and Development head

    GSK appoints scientist Barron as new Research and Development head

    Ruby Khatun Khatun10 Nov 2017 9:47 AM IST
    LONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
    Thousands of drugs at risk if no Brexit deal, companies warn

    Thousands of drugs at risk if no Brexit deal, companies warn

    Ruby Khatun Khatun10 Nov 2017 9:30 AM IST
    Supplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, European pharmaceutical...
    Mylan seeks EMA approval for 2 biosimilars

    Mylan seeks EMA approval for 2 biosimilars

    Ruby Khatun Khatun9 Nov 2017 10:32 AM IST
    New Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
    Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

    Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

    Ruby Khatun Khatun9 Nov 2017 10:16 AM IST
    New Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
    FDA clears common blood cell count test that offers faster results for patients and providers

    FDA clears common blood cell count test that offers faster results for patients and providers

    Ruby Khatun Khatun9 Nov 2017 9:49 AM IST
    The U.S. Food and Drug Administration (FDA) cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more...
    Mallinckrodt dives as sales of main drug Acthar disappoint

    Mallinckrodt dives as sales of main drug Acthar disappoint

    Ruby Khatun Khatun9 Nov 2017 9:37 AM IST
    Shares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok